Therefore, dose adjustment in clients with renal insufficiency or ESRD could be expected (Desk three and Desk 12). Decreasing the dose lowers peak serum drug concentrations and may compromise treatment efficacy. Determined by professional impression, the interval involving drug doses in patients with a creatinine clearance of thirty mL/min creatini